# OnCo record idea-cost-interchangeable-oncology-biosimilars (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-cost-interchangeable-oncology-biosimilars/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-cost-interchangeable-oncology-biosimilars" ;
  schema:name "Drop the extra switching studies for interchangeable oncology biosimilars"@en ;
  schema:description "US law lets a pharmacist swap an 'interchangeable' biosimilar without asking the prescriber, but earning that label used to need costly switching studies; the FDA now says those are usually unnecessary, which should be made permanent for cancer antibodies."@en ;
  schema:url <https://onco.cc/ideas/idea-cost-interchangeable-oncology-biosimilars/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.fda.gov/drugs/therapeutic-biologics-applications-bla/biosimilars> ;
  onco:institutions <https://onco.cc/institutions/fda-oce/>, <https://onco.cc/institutions/ema/> ;
  onco:terms <https://onco.cc/terms/biosimilar/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-regulatory-fragmentation/> .